SPDR S&P Biotech ETF (NYSEARCA:XBI) Stock Position Lifted by Cetera Advisor Networks LLC

Cetera Advisor Networks LLC boosted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 10.2% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 42,706 shares of the exchange traded fund’s stock after purchasing an additional 3,956 shares during the period. Cetera Advisor Networks LLC owned about 0.06% of SPDR S&P Biotech ETF worth $3,813,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in XBI. Verity Asset Management Inc. grew its position in SPDR S&P Biotech ETF by 7.9% in the third quarter. Verity Asset Management Inc. now owns 17,228 shares of the exchange traded fund’s stock worth $1,258,000 after acquiring an additional 1,266 shares in the last quarter. Prime Capital Investment Advisors LLC grew its position in SPDR S&P Biotech ETF by 52.6% in the fourth quarter. Prime Capital Investment Advisors LLC now owns 6,464 shares of the exchange traded fund’s stock worth $577,000 after acquiring an additional 2,228 shares in the last quarter. Sequoia Financial Advisors LLC bought a new stake in SPDR S&P Biotech ETF in the fourth quarter worth approximately $533,000. Y.D. More Investments Ltd grew its position in SPDR S&P Biotech ETF by 5,500.0% in the fourth quarter. Y.D. More Investments Ltd now owns 5,600 shares of the exchange traded fund’s stock worth $500,000 after acquiring an additional 5,500 shares in the last quarter. Finally, BOCHK Asset Management Ltd bought a new stake in SPDR S&P Biotech ETF in the fourth quarter worth approximately $36,000.

SPDR S&P Biotech ETF Stock Up 0.7 %

XBI stock opened at $92.01 on Tuesday. The company has a market capitalization of $7.01 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The firm has a 50 day moving average of $88.89 and a two-hundred day moving average of $89.43.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Further Reading

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.